日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer

RAS-GTP抑制剂可克服非小细胞肺癌中由致癌性和野生型RAS激活介导的对KRASG12C抑制剂的获得性耐药性

期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-25-0600
Solanki, Hitendra S; Shah, Harshit; Imbody, Denis; Desai, Bina; Kato, Ryoji; Miroshnychenko, Daria; Stern, Yaakov E; Majumder, Anurima; Sarcar, Bhaswati; Xieraili, Aobuli; Stewart, Paul A; Fang, Bin; Zhang, Yonghong; Yao, Jiqiang; Darville, Lancia N; Koomen, John M; Rix, Uwe; Evans, James W; Yang, Yu Chi; Ahler, Ethan; Marusyk, Andriy; Singh, Mallika; Aronchik, Ida; Haura, Eric B
肺癌
肿瘤
肿瘤免疫
细胞生物学
RAS
发表日期：2026
文献求助 收藏

In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer.

原位 RAS:RAF 结合与 KRASG12C 突变型非小细胞肺癌对 KRASG12C 抑制剂的反应相关

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-3714
Kato Ryoji, Solanki Hitendra S, Ozakinci Hilal, Desai Bina, Gundlapalli Harika, Yang Yu Chi, Aronchik Ida, Singh Mallika, Johnson Joseph, Marusyk Andriy, Boyle Theresa A, Haura Eric B
细胞生物学
肺癌
发表日期：2025
文献求助 收藏

Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L)

非小细胞肺癌患者接受 PD-1 抑制剂治疗后行化疗与单纯化疗的倾向评分加权分析 (WJOG10217L)

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2019-000350
Kato, Ryoji; Hayashi, Hidetoshi; Chiba, Yasutaka; Miyawaki, Eriko; Shimizu, Junichi; Ozaki, Tomohiro; Fujimoto, Daichi; Toyozawa, Ryo; Nakamura, Atsushi; Kozuki, Toshiyuki; Tanaka, Kentaro; Teraoka, Shunsuke; Usui, Kazuhiro; Nishino, Kazumi; Hataji, Osamu; Ota, Keiichi; Ebi, Noriyuki; Saeki, Sho; Akazawa, Yuki; Okuno, Motoyasu; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
细胞生物学
PD-1
发表日期：2020
文献求助 收藏

Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors

表皮生长因子受体酪氨酸激酶抑制剂治疗的表皮生长因子受体突变型非小细胞肺癌患者中，赫格林表达及其临床意义

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-019-55939-5
Yonesaka, Kimio; Iwama, Eiji; Hayashi, Hidetoshi; Suzuki, Shinichiro; Kato, Ryoji; Watanabe, Satomi; Takahama, Takayuki; Tanizaki, Junko; Tanaka, Kaoru; Takeda, Masayuki; Sakai, Kazuko; Azuma, Koichi; Chiba, Yasutaka; Atagi, Shinji; Nishio, Kazuto; Okamoto, Isamu; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
信号转导
细胞生物学
发表日期：2019
文献求助 收藏

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

一项多中心、II期临床研究，评估艾立布林联合S-1治疗晚期乳腺癌患者的疗效

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-019-6200-5
Iwasa, Tsutomu; Tsurutani, Junji; Watanabe, Satomi; Kato, Ryoji; Mizuno, Yutaka; Kojima, Yasuyuki; Takashima, Tsutomu; Matsunami, Nobuki; Morimoto, Takashi; Yamamura, Jun; Ohtani, Shoichiro; Tanabe, Yuko; Yoshinami, Tetsuhiro; Takano, Toshimi; Komoike, Yoshifumi; Nakagawa, Kazuhiko
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏

Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer

免疫相关不良事件与纳武利尤单抗治疗非小细胞肺癌疗效的关联

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2017.2925
Haratani, Koji; Hayashi, Hidetoshi; Chiba, Yasutaka; Kudo, Keita; Yonesaka, Kimio; Kato, Ryoji; Kaneda, Hiroyasu; Hasegawa, Yoshikazu; Tanaka, Kaoru; Takeda, Masayuki; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2018
文献求助 收藏

Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study

γ-氨基丁酸转氨酶基因多态性是癌症疼痛患者对阿片类镇痛药反应性的候选基因位点：一项探索性研究

期刊:Neuropsychopharmacology Reports
影响因子:1.5
doi:10.1002/npr2.12030
Yokoshima, Yaeko; Sumitani, Masahiko; Nishizawa, Daisuke; Nagashima, Makoto; Ikeda, Kazutaka; Kato, Ryoji; Hozumi, Jun; Abe, Hiroaki; Azuma, Kenji; Tsuchida, Rikuhei; Yamada, Yoshitsugu
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab

接受纳武利尤单抗治疗的非小细胞肺癌患者出现肿瘤假性进展相关的肿瘤周围磨玻璃样混浊

期刊:ESMO Open
影响因子:8.3
doi:10.1136/esmoopen-2016-000145
Kato, Ryoji; Hayashi, Hidetoshi; Tanizaki, Junko; Tanaka, Kaoru; Takeda, Masayuki; Nakagawa, Kazuhiko
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma

血清 CA 19-9 对晚期肺腺癌患者的预后价值

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-016-2897-6
Sato, Yuki; Fujimoto, Daichi; Uehara, Keiichiro; Shimizu, Ryoko; Ito, Jiro; Kogo, Mariko; Teraoka, Shunsuke; Kato, Ryoji; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Hamakawa, Hiroshi; Takahashi, Yutaka; Imai, Yukihiro; Tomii, Keisuke
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏

Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer

晚期非小细胞肺癌患者接受全身抗癌治疗期间肺炎的特征及其对预后的影响

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0168465
Fujimoto, Daichi; Kato, Ryoji; Morimoto, Takeshi; Shimizu, Ryoko; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Tomii, Keisuke
肺炎
肺癌
肿瘤
肿瘤免疫
细胞生物学
发表日期：2016
文献求助 收藏